Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice
/in Breast Cancer, Hyperthermia, International Publications /von 2008-09-27 / Surg. Today 2008;38(10):911-20Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators
/in Gastric Cancer, Hyperthermia, International Publications /von 2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-408A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
/in Hyperthermia, International Publications, Prostate Cancer /von 2008-08-01 / J Biomech Eng 2008 Aug;130(4):041016TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
/in Hyperthermia, International Publications, Malignant Melanoma /von 2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-71Regional hyperthermia in high-risk soft tissue sarcomas
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2008-07-01 / Curr Opin Oncol 2008 Jul;20(4):438-43Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2008-04-24 / Vaccine 2008 Jun;26(27-28):3540-9The importance of schedule in whole body thermochemotherapy
/in Breast Cancer, Hyperthermia, International Publications /von 2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-81Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
/in Hyperthermia, International Publications /von 2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-78Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses
/in Hyperthermia, International Publications /von 2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-56
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution